Metal attenuating therapies in neurodegenerative disease.
about
Redox processes in neurodegenerative disease involving reactive oxygen speciesRecent discoveries on the functions of astrocytes in the copper homeostasis of the brain: a brief update.Glutaredoxin1 protects neuronal cells from copper-induced toxicity.Structural characterization and biological evaluation of a clioquinol-ruthenium complex with copper-independent antileukaemic activity.Multifunctional iron-chelators with protective roles against neurodegenerative diseases.Copper and Alzheimer's Disease.
P2860
Metal attenuating therapies in neurodegenerative disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Metal attenuating therapies in neurodegenerative disease.
@en
Metal attenuating therapies in neurodegenerative disease.
@nl
type
label
Metal attenuating therapies in neurodegenerative disease.
@en
Metal attenuating therapies in neurodegenerative disease.
@nl
prefLabel
Metal attenuating therapies in neurodegenerative disease.
@en
Metal attenuating therapies in neurodegenerative disease.
@nl
P2093
P2860
P356
P1476
Metal attenuating therapies in neurodegenerative disease.
@en
P2093
Alexandra I Mot
Anthony G Wedd
David R Brown
Layla Sinclair
Marcus W Brazier
Steven J Collins
P2860
P304
P356
10.1586/ERN.11.170
P577
2011-12-01T00:00:00Z